Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1336, 2011-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bevacizumab puts the brakes on breast cancer growth . . .
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :
Access to resources
Recommend
Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer
Drug Safety, Vol. 35, Iss. 1, 2012-01 ,pp. :
Bevacizumab combo keeps breast cancer under control
Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. :
Bevacizumab: In First-Line Treatment of Metastatic Breast Cancer
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :
Bevacizumab boosts chemotherapy response in breast cancer
Inpharma, Vol. 1, Iss. 1377, 2003-01 ,pp. :